GW501516 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
| Property | Value | Notes |
|---|---|---|
| IUPAC name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid | Systematic name for GW501516 |
| CAS Registry Number | 317318-70-0 | Unique identifier for the parent compound |
| Molecular formula | C21H18F3NO3S2 | Includes carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur |
| Molecular weight | 453.5 g/mol | Approximate value for the neutral form |
| Appearance | White to off-white powder | Typical description for purified laboratory material |
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
== Description == The adult lesser mealworm beetle is roughly 6 mm long and widely oval in shape. It is shiny black or brown with reddish brown elytra, the color variable among individuals and changing with age. Much of the body surface is dotted with puncture-like impressions. The antennae are paler at the tips and are covered in tiny, yellowish hairs. The elytra have shallow longitudinal grooves. The eggs are narrow, whitish or tan, and about 1.5 mm long. The larvae somewhat resemble other mealworms, such as the common mealworm (Tenebrio molitor), but are smaller, measuring up to 11 mm long at the final subadult stage. They are tapering and segmented, with three pairs of legs toward the front end, and whitish when newly emerged from the egg and darken to a yellow-brown. They become pale when preparing to molt between instar stages six to 11 instars occur.
== Events == 6 January - The William and Mary founders in the Irish Sea off Milford Haven, Pembrokeshire, with the loss of all hands. 9 January - The ship Cecelia, on a voyage from Dublin to Barbados, founders in the Irish Sea off Holyhead, Anglesey, with the loss of all hands. 10 March - The ship Prosperous founders off Anglesey with the loss of all hands. 6 May - The first Welsh language version of the New Testament issued by the British and Foreign Bible Society is published. 1 October - The brig Mary runs aground on the Arklow Bank, in the Irish Sea and is wrecked with the loss of seven of the ten people on board. Two of the survivors are rescued by Mary, a ship homeported in Liverpool, Lancashire, whilst the third is rescued by Mary, a ship homeported in Amlwch, Anglesey. 25 October - The sloop Margaret, on a voyage from Bristol, Gloucestershire to Greenock, Renfrewshire, is wrecked near Holyhead, Anglesey, with the loss of all on board. 3 December - Ships affected by a storm in the Irish Sea include: Eliza, driven ashore at Cardigan, Pembrokeshire, on a voyage from Virginia, United States to Dublin. Her crew are rescued. John, on a voyage from Youghal, County Cork to Dublin, driven ashore at Caernarfon. Milford, driven ashore at Cardigan while on a voyage from Liverpool to Wilmington, Delaware, United States. Her crew are rescued. The first Nonconformist school in Wales is opened at Swansea. William Madocks obtains an Act of Parliament to allow him to construct a harbour at Portinllaen. William Owen Pughe inherits the estate of the Rev.
== Theories == Central theories are Diener's tripartite model of subjective well-being, Ryff's Six-factor Model of Psychological Well-being, Corey Keyes' work on flourishing, and Seligman's contributions to positive psychology and his theories on authentic happiness and P.E.R.M.A. Positive psychology is concerned with eudaimonia, "the good life" or flourishing, living according to what holds the greatest value in life – the factors that contribute the most to a well-lived and fulfilling life. While not attempting a strict definition of the good life, positive psychologists agree that one must live a happy, engaged, and meaningful life in order to experience "the good life". Martin Seligman referred to "the good life" as "using your signature strengths every day to produce authentic happiness and abundant gratification". According to Christopher Peterson, "eudaimonia trumps hedonism". Research on positive psychology, well-being, eudaimonia and happiness, and the theories of Diener, Ryff, Keyes and Seligmann cover a broad range of levels and topics, including "the biological, personal, relational, institutional, cultural, and global dimensions of life." Happiness was famously analyzed by Aristotle as being the sole ultimate goal of human existence, meaning that he viewed it the only thing important in its own right, not merely as a means to an end. The pursuit of happiness predicts both positive emotions and less depressive symptoms. People who prioritize happiness are more psychologically able, all else held equal.
Sources: en.wikipedia.org
This low gamma ray production rate makes it difficult to use for identification of the isotope; rather than gamma ray spectroscopy, alpha spectroscopy is the best method of measuring it. Owing to its much shorter half-life, a milligram of 210Po emits as many alpha particles per second as 5 grams of 226Ra (that is, a milligram is 5 curies). A few curies of 210Po emit a blue glow caused by excitation of surrounding air. 210Po occurs in minute amounts in nature, where it is the penultimate isotope in the uranium series decay chain. It is generated via beta decay from 210Pb and 210Bi. The astrophysical s-process is terminated by the decay of 210Po, as the neutron flux is insufficient to lead to further neutron captures in the short lifetime of 210Po. Instead, 210Po alpha decays to 206Pb, which then captures more neutrons to become 210Po and repeats the cycle, thus consuming the remaining neutrons. This results in a buildup of lead and bismuth, and ensures that heavier elements such as thorium and uranium are only produced in the much faster r-process.
One of the strategies I used to become more neurotypical was to pick out a random person on the street and follow them around for the entire day, I would carefully log all of their movements and observations I made. I still try to do this from time to time, but I get recognized a lot which makes it hard. In December 2024, Peters crashed his white BMW driving home from a restaurant security job on Cape Cod in Massachusetts, posting that he had fallen asleep off baclofen, a muscle relaxer he had recommended his viewers use to reduce anxiety. On April 14, 2026, while streaming in public with fellow influencer Androgenic, Peters experienced a drug overdose and was hospitalized; he had been using a combination of Adderall, dextromethorphan, pregabalin, ketamine and 1,4-Butanediol, referred to as the "pentastack" by Androgenic. Of the incident, Peters later said, "I didn't overdose or anything. I mean I just, literally, had not eaten that day, consumed too much alcohol, and just knocked out a little bit." He regards the substances he uses as "just a cope trying to feel neurotypical while being in public, but obviously that isn't a real solution."
When glucose is fermented, it enters glycolysis or the pentose phosphate pathway and is converted to pyruvate. From pyruvate, pathways branch out to form a number of end products (e.g. lactate). At several points, electrons are released and accepted by redox cofactors (NAD and ferredoxin). At later points, these cofactors donate electrons to their final acceptor and become oxidized. ATP is also formed at several points in the pathway.
Sources: en.wikipedia.org
=== Management of insulin resistance === The main methods of management involve exercise and diet change, in addition to treatment of PPID. The primary goal is reduction of weight in an obese animal. Diet changes include limiting pasture access and reducing or eliminating grain. Obese animals are often best maintained on a diet consisting of ration balancer and hay, fed at 1.5% body weight and decreased if needed. Feed should be selected based on low nonstructural carbohydrate (NSC) levels. Hay NSC levels may be reduced by soaking it in cold water for 30 minutes. Exercise is increased in nonlaminitic horses. Animals resistant to weight loss, despite diet and exercise changes, can be placed on levothyroxine to increase metabolism. Metformin can also be used to reduce glucose absorption through the intestinal tract.
=== Notable Don Cossacks === Don Cossacks noble families Kondraty Bulavin Alexei Kaledin Pyotr Krasnov Matvei Platov Stepan Razin Yermak Timofeyevich Ivan Turchaninov — Union army brigadier general in the American Civil War. Aleksandr Khanzhonkov
In medicine, chemical compounds from corals can potentially be used to treat cancer, neurological diseases, inflammation including arthritis, pain, bone loss, high blood pressure and for other therapeutic uses. Coral skeletons, e.g. Isididae are being researched for their potential near-future use for bone grafting in humans. Coral Calx, known as Praval Bhasma in Sanskrit, is widely used in traditional system of Indian medicine as a supplement in the treatment of a variety of bone metabolic disorders associated with calcium deficiency. In classical times ingestion of pulverized coral, which consists mainly of the weak base calcium carbonate, was recommended for calming stomach ulcers by Galen and Dioscorides.
Sources: en.wikipedia.org
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.
It is prohibited by the World Anti-Doping Agency as a hormone and metabolic modulator. Athletes who test positive for GW501516 can face sanctions, including suspensions and loss of results.
Cardarine is a common or trade-style name, while GW501516 is the research code for the same chemical entity. Some sources also use Endurobol or GSK-516. The names refer to the same compound, not distinct drugs.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.